Muscle atrophy in amyotrophic lateral sclerosis begins well before a person notices the first twitch or stumble. Research in animal models shows that metabolic shifts inside muscle fibers and early disconnections at the points where nerves meet muscle are already underway during what clinicians call the pre-symptomatic phase. By the time weakness becomes obvious, a cascade of protein breakdown, mitochondrial failure, and stem-cell exhaustion is in full swing. Understanding what happens to muscle tissue on either side of that clinical threshold changes how researchers think about diagnosis, treatment timing, and the handful of muscles that mysteriously resist the disease.
What Happens Inside Muscle Before Symptoms Appear
ALS is usually described as a disease of motor neurons, and it is. But the muscle itself is not a passive bystander waiting for its nerve supply to die. Studies in mice carrying ALS-linked gene mutations show that skeletal muscle shifts its fuel source months before any observable weakness. In one study using the widely studied SOD1 mouse model, researchers measured energy expenditure and fuel use at an early pre-symptomatic stage (around 55 days old) and again once symptoms had appeared (around 120 days). Even at the early time point, the mice were already burning more fat relative to carbohydrate than their healthy counterparts, a pattern that became far more pronounced once symptoms arrived.1iScience. Skeletal Muscle Metabolic Reprogramming Precedes Disease Onset in Mouse Models of Amyotrophic Lateral Sclerosis This metabolic reprogramming suggests that something is going wrong inside muscle cells long before denervation becomes severe enough to cause visible wasting.
At the same time, the body mounts a temporary defense. When some motor neurons begin to fail, surviving neighboring neurons can sprout new axon branches to reinnervate the orphaned muscle fibers, a process called compensatory sprouting. In ALS, there is evidence that this sprouting does occur at neuromuscular junctions, but the disease typically outpaces the repair effort.2PubMed Central. Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders For a while, you might lose a significant fraction of your motor neurons without feeling weak at all, because the remaining neurons pick up the slack. That hidden compensation is one reason ALS can smolder for months or even years before clinical onset, and it helps explain why diagnosis is so often delayed.
The Machinery of Muscle Breakdown
Once a motor neuron dies and its axon retracts from the muscle fiber, that fiber loses the electrical signals it needs to contract and maintain its size. The resulting denervation triggers a set of molecular responses inside the muscle cell. Two protein-degradation systems ramp up dramatically. The ubiquitin-proteasome system tags damaged or unneeded proteins for destruction, while autophagy engulfs larger cellular structures and breaks them down. In ALS, both pathways become overactive, and the balance between building new muscle protein and tearing it down tips heavily toward destruction.3PubMed Central. Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
These pathways are not unique to ALS. Denervation from a severed peripheral nerve, from spinal cord injury, or from prolonged bed rest activates similar molecular switches, including a family of transcription factors called FOXO proteins that turn on genes responsible for muscle protein breakdown.4PubMed. Cellular and molecular features of neurogenic skeletal muscle atrophy What makes ALS atrophy especially devastating is its relentlessness: in most other forms of denervation, the underlying cause can be treated or at least stabilized, giving the muscle a chance to be reinnervated. In ALS, motor neurons keep dying, so the muscle never gets that window.
Mitochondrial dysfunction adds another layer. The mitochondria inside ALS muscle fibers become damaged, impairing the cell’s ability to generate energy. This is more than a side effect of disuse. Research suggests that failing mitochondria in muscle can send destructive signals back toward the motor neuron through what is called a retrograde signaling cascade, potentially accelerating the very nerve death that caused the problem in the first place.5Neurological Sciences. Skeletal muscle dysfunction in amyotrophic lateral sclerosis: a mitochondrial perspective and therapeutic approaches That feedback loop complicates the traditional view that ALS is purely a disease that moves from nerve to muscle. The muscle may be actively participating in its own destruction.
How Weakness Spreads Through the Body
ALS typically starts in one spot. About two-thirds of people first notice weakness in a limb, often one hand or one foot. Others experience the disease first in the muscles controlling speech and swallowing, a pattern called bulbar onset.6PubMed Central. Amyotrophic lateral sclerosis: a clinical review From that initial site, the disease spreads to other body regions in a somewhat predictable pattern. A large study tracking over 900 patients found that people whose weakness began in one arm or leg were about three times more likely to see it spread horizontally (to the opposite arm or leg) than vertically (from arm to leg on the same side). Among those with bulbar onset, nearly a third eventually reported spread to the legs, while only a small percentage of patients who started with leg weakness later developed bulbar symptoms.7PubMed Central. Clinical spreading of muscle weakness in amyotrophic lateral sclerosis (ALS): a study in 910 patients
This spreading pattern reflects the progressive death of motor neuron pools in the spinal cord and brainstem. As each new group of neurons falls, the muscles they once controlled begin to atrophy. Clinically, a person might notice that the space between the bones on the back of their hand looks hollowed out as the small intrinsic hand muscles waste away, or that one calf has visibly thinned compared to the other. Fasciculations, the involuntary twitching visible under the skin, often accompany or even precede the wasting as motor neurons fire erratically before dying.
When the Diaphragm Gets Involved
Respiratory failure is what ultimately limits survival for most people with ALS, typically within two to five years of symptom onset.6PubMed Central. Amyotrophic lateral sclerosis: a clinical review The diaphragm, the dome-shaped muscle beneath the lungs that drives breathing, is subject to the same denervation and atrophy that hits limb muscles. As motor units supplying the diaphragm are lost, inspiratory strength drops, leading to poor oxygen exchange and a buildup of carbon dioxide. These problems often first show up during sleep, especially when lying on the back, because gravity’s effect on a weakened diaphragm compounds the problem.8PubMed Central. Diaphragmatic Neurophysiology and Respiratory Markers in ALS
One unsettling finding is that standard breathing tests do not reliably predict how badly the diaphragm has actually atrophied. A study examining diaphragm tissue from ALS patients found that every patient showed significant atrophy in both slow-twitch and fast-twitch muscle fibers, yet commonly used measures like vital capacity and maximal inspiratory pressure did not correlate well with the severity of that tissue-level wasting.9European Respiratory Journal. Human diaphragm atrophy in amyotrophic lateral sclerosis is not predicted by routine respiratory measures This disconnect means that by the time a breathing test comes back abnormal, diaphragm damage may be much further along than expected. Axial muscles along the spine tend to denervate in step with the diaphragm, suggesting that the motor neurons serving these midline structures are affected together.10PubMed. Association of paraspinal and diaphragm denervation in ALS
Bulbar dysfunction, the weakening of muscles controlling the tongue, throat, and face, compounds the picture. Speech becomes slurred, swallowing grows difficult, and the risk of aspiration rises. Managing these bulbar symptoms requires a multidisciplinary team involving neurologists, speech-language pathologists, dietitians, and others.11PubMed Central. Clinical Measures of Bulbar Dysfunction in ALS
Cramps and What Patients Actually Feel
Muscle atrophy is the visible outcome, but the experience of living through it involves a constellation of symptoms that do not always get enough attention. Cramps are among the most common and debilitating. In a longitudinal study following 33 ALS patients, only two never developed cramps at all, giving the condition an incidence over the study period of about 95 percent. A substantial proportion reported extraordinary cramping burdens: roughly a third experienced 60 or more cramps per month at some point, and about a quarter had months with 100 or more.12PubMed Central. The Natural History of Muscle Cramps in Amyotrophic Lateral Sclerosis Cramps were far more frequent in people with limb-onset disease compared to those with bulbar onset, and older patients reported significantly more cramping than younger ones. These cramps are not the benign charley horses that healthy people get after exercise. They reflect the hyperexcitability of dying motor neurons and the chaotic reinnervation attempts that leave muscle fibers on a hair trigger.
Imaging the Damage
For decades, the main way to detect muscle involvement in ALS was through electromyography (EMG), the needle test that records electrical activity inside muscles. It remains essential, but imaging tools are gaining ground. Muscle ultrasound and MRI can capture different facets of ALS-related degeneration: changes in muscle thickness and volume, increased water content associated with acute denervation, fatty infiltration that marks chronic neurogenic change, and abnormal echo patterns reflecting altered tissue architecture. A comprehensive review found that all selected imaging studies successfully captured these ALS-associated changes, with researchers tracking everything from fasciculation counts to metabolic and diffusion alterations.13PubMed Central. Muscle MRI and Muscle Ultrasound Applications in MND / ALS
Ultrasound has a practical advantage: it is portable, inexpensive, and quick. In one study of 59 recently diagnosed ALS patients compared to 20 healthy controls, the thickness of the abductor pollicis brevis (a small thumb muscle) was significantly reduced in ALS patients, and the echointensity of the muscle tissue was significantly higher, reflecting the replacement of healthy muscle with fibrotic or fatty tissue. These ultrasound biomarkers, especially thickness and echointensity, discriminated well between ALS patients and controls and correlated with clinical measures of disease severity.14PubMed. Quantitative neuromuscular ultrasound analysis as biomarkers in amyotrophic lateral sclerosis Blood biomarkers are also being refined. Neurofilament light chain concentrations, which reflect axonal damage, have shown moderate correlation with the rate of disease progression, although markers of muscle damage specifically have not correlated as well.15Brain Communications. Comparative analysis of neurofilaments and biomarkers of muscular damage in amyotrophic lateral sclerosis
Why the Eyes Keep Moving
One of the strangest features of ALS is that the muscles controlling eye movement are largely spared, even at end-stage disease. People who have lost the ability to speak, swallow, and breathe on their own can often still look around a room normally. This is not just a clinical curiosity; it offers clues about what makes some muscles resistant to the disease.
The neuromuscular junctions in extraocular muscles remain intact in ALS mice at end-stage disease, while limb and diaphragm junctions are devastated.16PubMed Central. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology Several molecular differences appear to underlie this resilience. Extraocular muscles express higher levels of certain Wnt signaling molecules within their nerve terminals. In a study comparing human extraocular and limb muscles, all four Wnt isoforms tested were present in most nerve profiles in eye muscles, while significantly fewer were positive in limb muscles. The researchers argued that Wnt signaling plays a protective role in preserving these junctions and that its disruption in limb muscles contributes to pathology.17PubMed Central. Wnt and extraocular muscle sparing in amyotrophic lateral sclerosis
Satellite cells, the resident stem cells responsible for muscle repair, add another piece. In ALS mice, hindlimb and diaphragm muscles show severe depletion of their satellite cell pools by end-stage disease. Extraocular muscles, by contrast, maintain their satellite cell populations and the integrity of their neuromuscular junctions throughout.18eLife. Distinct transcriptomic profile of satellite cells contributes to preservation of neuromuscular junctions in extraocular muscles of ALS mice Satellite cell function is one of several muscle-intrinsic properties, alongside metabolism and protein quality control, that researchers now believe shapes ALS outcomes independently of what is happening in the motor neuron.19PubMed. What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy Understanding why eye muscles resist the disease could eventually reveal targets for protecting the muscles that do not.
Support Cells at the Junction
The neuromuscular junction is not just a nerve terminal and a muscle fiber. Terminal Schwann cells wrap around the junction and play housekeeping roles: guiding nerve regrowth, clearing debris, and maintaining the local environment. In a study using ALS mice lacking the SOD1 gene, researchers found dramatic remodeling at the junction. The overlap between nerve terminals and the receptors on the muscle side dropped by about a third, while the area covered by terminal Schwann cells ballooned to roughly three times normal levels.20bioRxiv. Decoding muscle-resident Schwann cell dynamics during neuromuscular junction remodeling Whether this Schwann cell expansion represents a protective response or a maladaptive one is still being worked out, but it underscores that ALS disrupts a whole neighborhood of cell types at the junction, not just the nerve.
Exercise, Nutrition, and Emerging Therapies
The question of whether exercise helps or hurts in ALS has been debated for years. A recent systematic review and meta-analysis found that exercise significantly improved overall functional scores and walking test distance in ALS patients. Resistance exercise was the most effective type for preserving overall function, while aerobic exercise helped maintain forced vital capacity, a measure of lung function. Exercise did not, however, significantly reduce fatigue or improve maximal inspiratory pressure.21PubMed Central. The effect of exercise intervention on amyotrophic lateral sclerosis: a systematic review and meta-analysis The general consensus has shifted away from the old advice to rest and conserve energy. Moderate, supervised exercise appears to be safe and modestly beneficial, though it cannot halt disease progression.
Nutrition is another front. ALS patients often develop hypermetabolism, burning more calories at rest than normal, which combined with swallowing difficulty accelerates weight loss and muscle wasting. High-calorie nutritional therapy has been shown to safely improve body weight and BMI, though trials have not yet demonstrated a clear impact on functional decline or survival rates.22PubMed Central. The safety and effectiveness of high-calorie therapy for treating amyotrophic lateral sclerosis: a systematic review and meta-analysis A randomized trial of high-calorie enteral feeding found the approach was safe and tolerable, and the authors urged further study of nutritional interventions earlier in the disease course, when there might be more to preserve.23PubMed Central. Hypercaloric enteral nutrition in Amyotrophic Lateral Sclerosis: a randomized double-blind placebo-controlled trial
On the pharmaceutical front, one promising line of research aims to stabilize the neuromuscular junction directly rather than trying to save the motor neuron from above. Neurotrophic factors, molecules that support nerve growth and survival, have been investigated for decades in this context.24PubMed Central. Neuromuscular junction protection for the potential treatment of amyotrophic lateral sclerosis More recently, researchers tested an antibody called X-17 that activates MuSK, a receptor critical for maintaining the architecture of the neuromuscular junction. In ALS mice, X-17 treatment restored junction transmission, rescued nerve denervation, and prolonged lifespan.25Molecular Therapy. Before and After ALS: A Look at Muscle Atrophy The logic is compelling: if you can keep the junction intact and functioning, you buy the muscle time even as the motor neuron deteriorates upstream. These results are still preclinical, but they represent a shift in thinking about where in the nerve-to-muscle chain intervention might do the most good.
The Muscle as a Therapeutic Target
For most of ALS research history, the motor neuron received almost all the attention. The muscle was seen as a victim, nothing more. That view is changing. The evidence that muscle metabolism goes awry before symptoms, that mitochondrial dysfunction in muscle may feed back to accelerate motor neuron death, and that satellite cell fitness determines whether a junction can be maintained all point to the muscle itself as a site where intervention could matter. Researchers have begun to argue that ALS is better understood as a disease of the motor unit as a whole, a functional system that includes the motor neuron, its axon, the junction, and the muscle fiber together.19PubMed. What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy Treatments that only target the neuron while ignoring the metabolic crisis in the muscle or the structural collapse at the junction are working with an incomplete map. The before-and-after picture of ALS muscle atrophy is not a simple story of denervation followed by wasting. It is a story of metabolic reprogramming, failed repair, molecular feedback loops, and selective vulnerability that differs from one muscle group to the next. The muscles that resist the disease have as much to teach as the ones that succumb.